As Mo points out, the fact that they mention GILD's Remdesivir, a drug that does NOT work well by itself but that with Brilacidin can have efficacy increased and more importantly to the GILD executives, increase sales and perhaps keep market share as more effective drugs are developed --

this has to be getting their attention.

Remdesivir would probably not even have been approved, based on science, if the situation were not so dire. Some way for them to keep selling this crap is going to be real important to them.